Cutaneous tuberculosis: epidemiological, clinical, diagnostic and therapeutic update

Detalhes bibliográficos
Autor(a) principal: Brito,Arival Cardoso de
Data de Publicação: 2022
Outros Autores: Oliveira,Clivia Maria Moraes de, Unger,Deborah Aben-Athar, Bittencourt,Maraya de Jesus Semblano
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Anais brasileiros de dermatologia (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962022000200129
Resumo: Abstract Tuberculosis is certainly one of the diseases considered to be ancient on planet Earth. The etiological agent of tuberculosis is Mycobacterium tuberculosis. This terrible bacterial infection still results in severe socioeconomic consequences to date, and its complete eradication represents a great challenge. It constitutes one of the most important public health problems in developing countries. According to the World Health Organization, this infection results in more than 4,000 deaths daily worldwide, with 10.4 million being affected annually and 1.5 million deaths from TB every year. With the emergence of the HIV/AIDS pandemic, the disease became the main cause of morbidity and mortality in patients infected with the human immunodeficiency virus. Cutaneous tuberculosis is a rare infection that represents 1% to 1.5% of extrapulmonary tuberculosis, whose etiological agents are Mycobacterium tuberculosis, Mycobacterium bovis, and the attenuated form of the bacillus Calmette-Guérin (BCG vaccine). Cutaneous tuberculosis can be exogenous; endogenous: caused by contiguity or autoinoculation and by hematogenous spread; induced by the Calmette-Guérin bacillus and manifest as a tuberculid. The diagnosis of the infection is carried out through the direct test, culture, histopathology, tuberculin skin test, polymerase chain reaction, interferon-gamma release assay, and genotyping. Drugs used comprise isoniazid, rifampicin, pyrazinamide and ethambutol.x
id SBD-1_c502c634018ca02bb27b318e574ada8c
oai_identifier_str oai:scielo:S0365-05962022000200129
network_acronym_str SBD-1
network_name_str Anais brasileiros de dermatologia (Online)
repository_id_str
spelling Cutaneous tuberculosis: epidemiological, clinical, diagnostic and therapeutic updateEpidemiologyMycobacterium tuberculosisPathogenesis, homeopathicTuberculosisTuberculosis, cutaneousAbstract Tuberculosis is certainly one of the diseases considered to be ancient on planet Earth. The etiological agent of tuberculosis is Mycobacterium tuberculosis. This terrible bacterial infection still results in severe socioeconomic consequences to date, and its complete eradication represents a great challenge. It constitutes one of the most important public health problems in developing countries. According to the World Health Organization, this infection results in more than 4,000 deaths daily worldwide, with 10.4 million being affected annually and 1.5 million deaths from TB every year. With the emergence of the HIV/AIDS pandemic, the disease became the main cause of morbidity and mortality in patients infected with the human immunodeficiency virus. Cutaneous tuberculosis is a rare infection that represents 1% to 1.5% of extrapulmonary tuberculosis, whose etiological agents are Mycobacterium tuberculosis, Mycobacterium bovis, and the attenuated form of the bacillus Calmette-Guérin (BCG vaccine). Cutaneous tuberculosis can be exogenous; endogenous: caused by contiguity or autoinoculation and by hematogenous spread; induced by the Calmette-Guérin bacillus and manifest as a tuberculid. The diagnosis of the infection is carried out through the direct test, culture, histopathology, tuberculin skin test, polymerase chain reaction, interferon-gamma release assay, and genotyping. Drugs used comprise isoniazid, rifampicin, pyrazinamide and ethambutol.xSociedade Brasileira de Dermatologia2022-04-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962022000200129Anais Brasileiros de Dermatologia v.97 n.2 2022reponame:Anais brasileiros de dermatologia (Online)instname:Sociedade Brasileira de Dermatologia (SBD)instacron:SBD10.1016/j.abd.2021.07.004info:eu-repo/semantics/openAccessBrito,Arival Cardoso deOliveira,Clivia Maria Moraes deUnger,Deborah Aben-AtharBittencourt,Maraya de Jesus Semblanoeng2022-04-18T00:00:00Zoai:scielo:S0365-05962022000200129Revistahttp://www.anaisdedermatologia.org.br/https://old.scielo.br/oai/scielo-oai.phpabd@sbd.org.br||revista@sbd.org.br1806-48410365-0596opendoar:2022-04-18T00:00Anais brasileiros de dermatologia (Online) - Sociedade Brasileira de Dermatologia (SBD)false
dc.title.none.fl_str_mv Cutaneous tuberculosis: epidemiological, clinical, diagnostic and therapeutic update
title Cutaneous tuberculosis: epidemiological, clinical, diagnostic and therapeutic update
spellingShingle Cutaneous tuberculosis: epidemiological, clinical, diagnostic and therapeutic update
Brito,Arival Cardoso de
Epidemiology
Mycobacterium tuberculosis
Pathogenesis, homeopathic
Tuberculosis
Tuberculosis, cutaneous
title_short Cutaneous tuberculosis: epidemiological, clinical, diagnostic and therapeutic update
title_full Cutaneous tuberculosis: epidemiological, clinical, diagnostic and therapeutic update
title_fullStr Cutaneous tuberculosis: epidemiological, clinical, diagnostic and therapeutic update
title_full_unstemmed Cutaneous tuberculosis: epidemiological, clinical, diagnostic and therapeutic update
title_sort Cutaneous tuberculosis: epidemiological, clinical, diagnostic and therapeutic update
author Brito,Arival Cardoso de
author_facet Brito,Arival Cardoso de
Oliveira,Clivia Maria Moraes de
Unger,Deborah Aben-Athar
Bittencourt,Maraya de Jesus Semblano
author_role author
author2 Oliveira,Clivia Maria Moraes de
Unger,Deborah Aben-Athar
Bittencourt,Maraya de Jesus Semblano
author2_role author
author
author
dc.contributor.author.fl_str_mv Brito,Arival Cardoso de
Oliveira,Clivia Maria Moraes de
Unger,Deborah Aben-Athar
Bittencourt,Maraya de Jesus Semblano
dc.subject.por.fl_str_mv Epidemiology
Mycobacterium tuberculosis
Pathogenesis, homeopathic
Tuberculosis
Tuberculosis, cutaneous
topic Epidemiology
Mycobacterium tuberculosis
Pathogenesis, homeopathic
Tuberculosis
Tuberculosis, cutaneous
description Abstract Tuberculosis is certainly one of the diseases considered to be ancient on planet Earth. The etiological agent of tuberculosis is Mycobacterium tuberculosis. This terrible bacterial infection still results in severe socioeconomic consequences to date, and its complete eradication represents a great challenge. It constitutes one of the most important public health problems in developing countries. According to the World Health Organization, this infection results in more than 4,000 deaths daily worldwide, with 10.4 million being affected annually and 1.5 million deaths from TB every year. With the emergence of the HIV/AIDS pandemic, the disease became the main cause of morbidity and mortality in patients infected with the human immunodeficiency virus. Cutaneous tuberculosis is a rare infection that represents 1% to 1.5% of extrapulmonary tuberculosis, whose etiological agents are Mycobacterium tuberculosis, Mycobacterium bovis, and the attenuated form of the bacillus Calmette-Guérin (BCG vaccine). Cutaneous tuberculosis can be exogenous; endogenous: caused by contiguity or autoinoculation and by hematogenous spread; induced by the Calmette-Guérin bacillus and manifest as a tuberculid. The diagnosis of the infection is carried out through the direct test, culture, histopathology, tuberculin skin test, polymerase chain reaction, interferon-gamma release assay, and genotyping. Drugs used comprise isoniazid, rifampicin, pyrazinamide and ethambutol.x
publishDate 2022
dc.date.none.fl_str_mv 2022-04-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962022000200129
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962022000200129
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1016/j.abd.2021.07.004
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Dermatologia
publisher.none.fl_str_mv Sociedade Brasileira de Dermatologia
dc.source.none.fl_str_mv Anais Brasileiros de Dermatologia v.97 n.2 2022
reponame:Anais brasileiros de dermatologia (Online)
instname:Sociedade Brasileira de Dermatologia (SBD)
instacron:SBD
instname_str Sociedade Brasileira de Dermatologia (SBD)
instacron_str SBD
institution SBD
reponame_str Anais brasileiros de dermatologia (Online)
collection Anais brasileiros de dermatologia (Online)
repository.name.fl_str_mv Anais brasileiros de dermatologia (Online) - Sociedade Brasileira de Dermatologia (SBD)
repository.mail.fl_str_mv abd@sbd.org.br||revista@sbd.org.br
_version_ 1752126424661098496